Sesamol and naringenin reverse the effect of rotenone-induced PD rat model

Neuroscience

Volumn 254, Issue , 2013, Pages 379-394

  Sonia Angeline, M ^a   Sarkar, A ^a   Anand, K ^a   Ambasta, R K ^a   Kumar, P ^a,b,c  

^a VIT UNIVERSITY   (India)

^b DELHI TECHNOLOGICAL UNIVERSITY   (India)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Naringenin; Neuroprotection; Parkinson's disease; Rotenone; Sesamol

Indexed keywords

CASPASE; DJ 1 PROTEIN; HEAT SHOCK PROTEIN 70; NARINGENIN; NEUROPROTECTIVE AGENT; PARKIN; PROTEIN CHIP; SESAMOL; TYROSINE 3 MONOOXYGENASE; UBIQUITIN; UNCLASSIFIED DRUG; 1,3 BENZODIOXOLE DERIVATIVE; FLAVANONE DERIVATIVE; PHENOL DERIVATIVE; ROTENONE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; BRAIN REGION; CELL DEATH; CONTROLLED STUDY; CORPUS STRIATUM; DOWN REGULATION; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; MALE; MUSCLE STRENGTH; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SUBSTANTIA NIGRA; TREATMENT DURATION; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; PARKINSON DISEASE, SECONDARY; PATHOLOGY; TOXICITY; WISTAR RAT;

ANIMALS; BENZODIOXOLES; DISEASE MODELS, ANIMAL; FLAVANONES; MALE; PARKINSON DISEASE, SECONDARY; PHENOLS; RATS; RATS, WISTAR; ROTENONE;

EID: 84887606704     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.09.029     Document Type: Article

References (58)

1. Ahmad M., Saleem S., Ahmad A.S., Yousuf S., Ansari M.A., Khan M.B., Ishrat T., Chaturvedi R.K., Agrawal A.K., Islam F. Ginkgo biloba affords dose dependent protection against 6 hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences. J Neurochem 2005, 93:94-104.
2. Ahmad S., Khan M.B., Hoda M.N., Bhatia K., Haque R., Fazili I.S., Jamal A., Khan J.S., Katare D.P. Neuroprotective effect of sesame seed oil in 6-hydroxydopamine induced neurotoxicity in mice model: cellular, biochemical and neurochemical evidence. Neurochem Res 2012, 37:516-526.
3. Alam M., Schmidt W.J. Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats. Behav Brain Res 2002, 136:317-324.
4. Ambasta R.K., Schreiber J.G., Janiszewski M., Busse R., Brandes R.P. Noxa1 is a central component of the smooth muscle NADPH oxidase in mice. Free Radic Biol Med 2006, 41:193-201.
5. Ansari M.A., Ahmad A.S., Ahmad M., Salim S., Yousuf S., Ishrat T., Islam F. Selenium protects cerebral ischemia in rat brain mitochondria. Biol Trace Elem Res 2004, 101:73-86.
6. Barnéoud P., Mazadier M., Miquet J.M., Parmentier S., Dubédat P., Doble A., Boireau A. Neuroprotective effects of riluzole on a model of Parkinson's disease in the rat. Neuroscience 1996, 74:971-983.
7. Barzilai A., Melamed E. Molecular mechanisms of selective dopaminergic neuronal death in Parkinson's disease. Trends Mol Med 2003, 9:126-132.
8. Braak H., Del Tredici K., Rüb U., de Vos R.A., Jansen Steur E.N., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003, 24:197-211.
9. Brocks D.R. Anticholinergic drugs used in Parkinson's disease: an overlooked class of drugs from a pharmacokinetic perspective. J Pharm Pharm Sci 1999, 2:39-46.
10. Cannon J.R., Tapias V., Na H.M., Honick A.S., Drolet R.E., Greenamyre J.T. A highly reproducible rotenone model of Parkinson's disease. Neurobiol Dis 2009, 34:279-290.
11. Casarrubea M., Sorbera F., Santangelo A., Crescimanno G. Microstructure of rat behavioral response to anxiety in hole-board. Neurosci Lett 2010, 481:82-87.
12. Chandrasekaran V.R., Hsu D.Z., Liu M.Y. The protective effect of sesamol against mitochondrial oxidative stress and hepatic injury in acetaminophen-overdosed rats. Shock 2009, 32:89-93.
13. Chang C.C., Lu W.J., Ong E.T., Chiang C.W., Lin S.C., Huang S.Y., Sheu J.R. A novel role of sesamol in inhibiting NF-κB-mediated signaling in platelet activation. J Biomed Sci 2011, 18:93.
14. Cheng F., Breen K. On the ability of four flavonoids, baicilein, luteolin, naringenin and quercetin, to suppress the Fenton reaction of the iron ATP complex. Biometals 2000, 13:77-83.
15. Collins K.L., Lehmann E.M., Patil P.G. Deep brain stimulation for movement disorders. Neurobiol Dis 2010, 38:338-345.
16. Corti O., Brice A. Of Parkin and Parkinson's: light and dark sides of a multifaceted E3 ubiquitin-protein ligase. Drug Discov Today 2007, 4:121-127.
17. Datla K.P., Christidou M., Widmer W.W., Rooprai H.K., Dexter D.T. Tissue distribution and neuroprotective effects of citrus flavonoid tangeretin in a rat model of Parkinson's disease. Neuroreport 2001, 12:3871-3875.
18. Ebrahimi-Fakhari D., Wahlster L., McLean P.J. Molecular chaperones in Parkinson's disease - present and future. J Parkinsons Dis 2011, 1:299-320.
19. Heo H.J., Kim D.O., Shin S.C., Mj Kim., Kim B.G., Shin D.H. Effect of antioxidant fiavonone, naringenin, from Citrus junos on neuroprotection. J Agric Food Chem 2004, 52:1520-1525.
20. Hou R.C.W., Chen Y.S., Chen C.H., Chen Y.H., Jeng K.C.G. Protective effect of 1,2,4-benzenetriol on LPS-induced NO production by BV2 microglial cells. J Biomed Sci 2006, 13:89-99.
21. Hsu D.Z., Chen K.T., Li Y.H., Chuang Y.C., Liu M.Y. Sesamol delays mortality and attenuates hepatic injury after cecal ligation and puncture in rats: role of oxidative stress. Shock 2006, 25:528-537.
22. Imai Y., Soda M., Hatakeyama S., Akagi T., Hashikawa T., Nakayama K.I., Takahashi R. CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity. Mol Cell 2002, 10:55-67.
23. Jan K.C., Ho C.T., Hwang L.S. Bioavailability and tissue distribution of sesamol in rat. J Agric Food Chem 2008, 56:7032-7037.
24. Kampinga H.H., Kanon B., Salomons F.A., Kabakov A.E., Patterson C. Overexpression of the cochaperone CHIP enhances Hsp70-dependent folding activity in mammalian cells. Mol Cell Biol 2003, 23:4948-4958.
25. Kapoor R., Rizvi F., Kakkar P. Naringenin prevents high glucose-induced mitochondria-mediated apoptosis involving AIF, Endo-G and caspases. Apoptosis 2013, 18:9-27.
26. Kaul T.N., Middlenton E., Ogra P.L. Antiviral effect of flavonoids on human viruses. J Med Virol 1985, 15:71-79.
27. Kim H.J., Song J.Y., Park H.J., Park H.K., Yun D.H., Chung J.H. Naringin protects against rotenone-induced apoptosis in human neuroblastoma SH-SY5Y cells. Korean J Physiol Pharmacol 2009, 13:281-285.
28. Kumar P., Ambasta R.K., Veereshwarayya V., Rosen K.M., Kosik K.S., Band H., Mestril R., Patterson C., Querfurth H.W. CHIP and HSPs interact with b-APP in a proteasome-dependent manner and influence Ab metabolism. Hum Mol Genet 2007, 16:2007848-2007864.
29. Kumar P., Kalonia H., Kumar A. Sesamol attenuate 3-nitropropionic acid-induced Huntington-like behavioral, biochemical, and cellular alterations in rats. J Asian Nat Prod Res 2009, 11:439-450.
30. Kumar B., Kuhad A., Chopra K. Neuropsychopharmacological effect of sesamol in unpredictable chronic mild stress model of depression: behavioral and biochemical evidences. Psychopharmacology (Berl) 2011, 214:819-828.
31. Kumar P., Pradhan K., Karunya R., Ambasta R.K., Querfurth H.W. Cross-functional E3 ligases Parkin and C-terminus Hsp70-interacting protein in neurodegenerative disorders. J Neurochem 2012, 120:350-370.
32. Lahaie-Collins V., Bournival J., Plouffe M., Carange J., Martinoli M.G. Sesamin modulates tyrosine hydroxylase, superoxide dismutase, catalase, inducible no synthase and interleukin-6 expression in dopaminergic cells under Mpp+-induced oxidative stress. Oxid Med Cell Longev 2008, 1:54-62.
33. Lang A.E., Lozano A.M. Parkinson's disease. First of two parts. N Engl J Med 1998, 339:1044-1053.
34. Lapointe N., St-Hilaire M., Martinoli M.G., Blanchet J., Gould P., Rouillard C., Cicchetti F. Rotenone induces non-specific central nervous system and systemic toxicity. FASEB J 2004, 18:717-719.
35. Lev N., Roncevic D., Ickowicz D., Melamed E., Offen D. Role of DJ-1 in Parkinson's disease. J Mol Neurosci 2006, 29:215-225.
36. Li C.Y., Lee J.S., Ko Y.G., Kim J.I., Seo J.S. Heat shock protein 70 inhibits apoptosis downstream of cytochrome c release and upstream of caspase-3 activation. J Biol Chem 2000, 275:25665-25671.
37. Liu Y., Steinacker J.M. Changes in skeletal muscle heat shock proteins: pathological significance. Front Biosci 2001, 6:12-25.
38. Luo G.R., Chen S., Le W.D. Are heat shock proteins therapeutic target for Parkinson's disease?. Int J Biol Sci 2007, 3:20-26.
39. Misra S., Tiwari V., Kuhad A., Chopra K. Modulation of nitrergic pathway by sesamol prevents cognitive deficits and associated biochemical alterations in intracerebroventricular streptozotocin administered rats. Eur J Pharmacol 2011, 659:177-186.
40. Moore D.J., West A.B., Dawson V.L., Dawson T.M. Molecular pathophysiology of Parkinson's disease. Annu Rev Neurosci 2005, 28:57-87.
41. Newhouse K., Hsuan S.L., Chang S.H., Cai B., Wang Y., Xia Z. Rotenone-induced apoptosis is mediated by p38 and JNK MAP Kinases in human dopaminergic SH-SY5Y cells. Toxicol Sci 2004, 79:137-146.
42. Pardridge W.M. Tyrosine hydroxylase replacement in experimental Parkinson's disease with transvascular gene therapy. NeuroRx 2005, 2:129-138.
43. Prasad N.R., Mahesh T., Menon V.P., Jeevanram R.K., Pugalendi K.V. Photoprotective effect of sesamol on UVB-radiation induced oxidative stress in human blood lymphocytes in vitro. Environ Toxicol Pharmacol 2005, 20:1-5.
44. Ravagnan L., Gurbuxani S., Susin S.A., Maisse C., Daugas E., Zamzami N., Mak T., Jäättelä M., Penninger J.M., Garrido C., Kroemer G. Heat-shock protein 70 antagonizes apoptosis-inducing factor. Nat Cell Biol 2001, 3:839-843.
45. Rosen K.M., Veereshwarayya V., Moussa C.E., Fu Q., Goldberg M.S., Schlossmacher M.G., Shen J., Querfurth H.W. Parkin protects against mitochondrial toxins and beta-amyloid accumulation in skeletal muscle cells. J Biol Chem 2006, 281:12809-12816.
46. Rosen K.M., Moussa C.E.-H., Lee H.-K., Kumar P., Kitada T., Qin G., Fu Q., Querfurth H.W. Parkin reverses intracellular beta-Amyloid accumulation and its negative effects on proteasome function. J Neurosci Res 2010, 88:167-178.
47. Shulman M., Cohen M., Soto-Gutierrez A., Yagi H., Wang H., Goldwasser J., Lee-Parsons C.W., Benny-Ratsaby O., Yarmush M.L., Nahmias Y. Enhancement of naringenin bioavailability by complexation with hydroxypropoyl-β-cyclodextrin. PLoS One 2011, 6:e18033.
48. Sonia Angeline M., Chaterjee P., Anand K., Ambasta R.K., Kumar P. Rotenone induced Parkinsonism elicit the behavioral impairments along with differential expression of parkin, heat shock proteins and caspase in rat. Neuroscience 2012, 220:291-301.
49. Spencer J.P.E. The interactions of flavonoids within neuronal signalling pathways. Gen Nutr 2007, 2:257-273.
50. Taira T., Saito Y., Niki T., Iguchi-Ariga S.M.M., Takahashi K., Ariga H. DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep 2004, 5:213-218.
51. Tenkova T.I., Goldberg M.P. A modified silver technique (de Olmos stain) for assessment of neuronal and axonal degeneration. Methods Mol Biol 2007, 399:31-39.
52. Uchida M., Nakajn S., Toyoshima M. Antioxidative effect of sesamol and related compounds on lipid peroxidation. Biol Pharm Bull 1996, 19:623-626.
53. van Doorn W.G. Plant programmed cell death and the point of no return. Trends Plant Sci 2005, 10:478-483.
54. Vauzour D., Vafeiadou K., Rodriguez-Mateos A., Rendeiro C., Spencer J.P. The neuroprotective potential of flavonoids: a multiplicity of effects. Genes Nutr 2008, 3(3-4):115-126.
55. Wood-Kaczmar A., Gandhi S., Wood N.W. Understanding the molecular causes of Parkinson's disease. Trends Mol Med 2006, 12:521-528.
56. Xiong N., Huang J., Zhang Z., Zhang Z., Xiong J., Liu X., Jia M., Wang F., Chen C., Cao X., Liang Z., Sun S., Lin Z., Wang T. Stereotaxical infusion of rotenone: a reliable rodent model for Parkinson's disease. PLoS One 2009, 4:e7878.
57. Youdim K.A., Spencer J.P., Schroeter H., Rice-Evans C. Dietary flavonoids as potential neuroprotectants. Biol Chem 2002, 383:503-519.
58. Zbarsky V., Datla K.P., Parkar S., Rai D.K., Aruoma O.I., Dexter D.T. Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease. Free Radic Res 2005, 39:1119-1125.